{"entity":{"type":"insider","cik":"0001394522","url":"/insider/0001394522","json_url":"/insider/0001394522.json","name":"Tobias Jeffrey K","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":21,"first":"2009-11-30","last":"2015-02-12","span_basis":"filed_date"},"name_variants":[{"name":"Tobias Jeffrey K","source":"filing","n_filings":21,"first_seen":"2009-11-30","last_seen":"2015-02-12"}],"transactions":[{"id":8217436,"accession":"0001232524-15-000017","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001232524-15-000017","line_url":"/filing/0001232524-15-000017","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, R&D & CMO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":166.82364,"price_display":"166.82","price_state":"stated","total_value":834118.2,"total_display":"834,118.20","total_whole":"834,118","shares_owned_after":37063.0,"shares_owned_after_display":"37,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-10","filed_date":"2015-02-12","scope":"insider","n_lines":2},{"id":7057529,"accession":"0001232524-14-000146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-14-000146","line_url":"/filing/0001232524-14-000146#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4598.0,"shares_display":"4,598","price_per_share":170.1242,"price_display":"170.12","price_state":"stated","total_value":782231.0716,"total_display":"782,231.07","total_whole":"782,231","shares_owned_after":34940.0,"shares_owned_after_display":"34,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-11-25","scope":"insider"},{"id":6882567,"accession":"0001232524-14-000145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-14-000145","line_url":"/filing/0001232524-14-000145#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":173.32,"price_display":"173.32","price_state":"stated","total_value":173320.0,"total_display":"173,320.00","total_whole":"173,320","shares_owned_after":39538.0,"shares_owned_after_display":"39,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-14","filed_date":"2014-11-18","scope":"insider"},{"id":6441041,"accession":"0001232524-14-000125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-14-000125","line_url":"/filing/0001232524-14-000125#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":154.04,"price_display":"154.04","price_state":"stated","total_value":154040.0,"total_display":"154,040.00","total_whole":"154,040","shares_owned_after":40538.0,"shares_owned_after_display":"40,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-10","filed_date":"2014-10-14","scope":"insider"},{"id":6341059,"accession":"0001232524-14-000123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-14-000123","line_url":"/filing/0001232524-14-000123#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":171.22,"price_display":"171.22","price_state":"stated","total_value":171220.0,"total_display":"171,220.00","total_whole":"171,220","shares_owned_after":41538.0,"shares_owned_after_display":"41,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-12","filed_date":"2014-09-15","scope":"insider"},{"id":6751653,"accession":"0001232524-14-000111","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001232524-14-000111","line_url":"/filing/0001232524-14-000111#line-4","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4933.0,"shares_display":"4,933","price_per_share":135.42,"price_display":"135.42","price_state":"stated","total_value":668026.86,"total_display":"668,026.86","total_whole":"668,027","shares_owned_after":42538.0,"shares_owned_after_display":"42,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-11","filed_date":"2014-08-13","scope":"insider"},{"id":6504901,"accession":"0001232524-14-000065","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001232524-14-000065","line_url":"/filing/0001232524-14-000065#line-3","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":146.24,"price_display":"146.24","price_state":"stated","total_value":438720.0,"total_display":"438,720.00","total_whole":"438,720","shares_owned_after":47103.0,"shares_owned_after_display":"47,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-09","filed_date":"2014-06-11","scope":"insider"},{"id":6562281,"accession":"0001232524-14-000056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001232524-14-000056","line_url":"/filing/0001232524-14-000056#line-1","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":128.01,"price_display":"128.01","price_state":"stated","total_value":128010.0,"total_display":"128,010.00","total_whole":"128,010","shares_owned_after":47103.0,"shares_owned_after_display":"47,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-16","filed_date":"2014-05-20","scope":"insider"},{"id":6562275,"accession":"0001232524-14-000035","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001232524-14-000035","line_url":"/filing/0001232524-14-000035#line-3","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":128.54,"price_display":"128.54","price_state":"stated","total_value":385620.0,"total_display":"385,620.00","total_whole":"385,620","shares_owned_after":48103.0,"shares_owned_after_display":"48,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-14","filed_date":"2014-04-16","scope":"insider"},{"id":6790775,"accession":"0001232524-14-000029","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001232524-14-000029","line_url":"/filing/0001232524-14-000029#line-3","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":152.99,"price_display":"152.99","price_state":"stated","total_value":458970.0,"total_display":"458,970.00","total_whole":"458,970","shares_owned_after":48103.0,"shares_owned_after_display":"48,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-10","filed_date":"2014-03-12","scope":"insider"},{"id":6790764,"accession":"0001232524-14-000018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001232524-14-000018","line_url":"/filing/0001232524-14-000018#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":165.46,"price_display":"165.46","price_state":"stated","total_value":496380.0,"total_display":"496,380.00","total_whole":"496,380","shares_owned_after":41777.0,"shares_owned_after_display":"41,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-27","filed_date":"2014-03-03","scope":"insider"},{"id":6621059,"accession":"0001232524-14-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001232524-14-000003","line_url":"/filing/0001232524-14-000003#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2560.0,"shares_display":"2,560","price_per_share":152.83,"price_display":"152.83","price_state":"stated","total_value":391244.8,"total_display":"391,244.80","total_whole":"391,245","shares_owned_after":44777.0,"shares_owned_after_display":"44,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-10","filed_date":"2014-02-12","scope":"insider"},{"id":4311160,"accession":"0001232524-13-000117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001232524-13-000117","line_url":"/filing/0001232524-13-000117#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1325.0,"shares_display":"1,325","price_per_share":117.8,"price_display":"117.80","price_state":"stated","total_value":156085.0,"total_display":"156,085.00","total_whole":"156,085","shares_owned_after":44777.0,"shares_owned_after_display":"44,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-09","filed_date":"2013-12-11","scope":"insider"},{"id":5456524,"accession":"0001232524-13-000114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001232524-13-000114","line_url":"/filing/0001232524-13-000114#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2373.0,"shares_display":"2,373","price_per_share":98.5,"price_display":"98.50","price_state":"stated","total_value":233740.5,"total_display":"233,740.50","total_whole":"233,741","shares_owned_after":44405.0,"shares_owned_after_display":"44,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-11","filed_date":"2013-11-13","scope":"insider"},{"id":4490645,"accession":"0001232524-13-000106","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001232524-13-000106","line_url":"/filing/0001232524-13-000106","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":82.6236,"price_display":"82.62","price_state":"stated","total_value":413118.0,"total_display":"413,118.00","total_whole":"413,118","shares_owned_after":45005.0,"shares_owned_after_display":"45,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-14","filed_date":"2013-10-16","scope":"insider","n_lines":2},{"id":4879076,"accession":"0001232524-13-000101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001232524-13-000101","line_url":"/filing/0001232524-13-000101#line-2","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":87.11,"price_display":"87.11","price_state":"stated","total_value":435550.0,"total_display":"435,550.00","total_whole":"435,550","shares_owned_after":44405.0,"shares_owned_after_display":"44,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-09","filed_date":"2013-09-10","scope":"insider"},{"id":5201834,"accession":"0001232524-13-000083","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001232524-13-000083","line_url":"/filing/0001232524-13-000083#line-3","is_derivative":false,"issuer_cik":"0001232524","issuer_name":"Jazz Pharmaceuticals plc","issuer_ticker":"JAZZ","issuer_name_source":null,"issuer_url":"/issuer/0001232524","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP, Research & Dev and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Dev and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Dev and CMO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":80.77,"price_display":"80.77","price_state":"stated","total_value":605775.0,"total_display":"605,775.00","total_whole":"605,775","shares_owned_after":44405.0,"shares_owned_after_display":"44,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-12","filed_date":"2013-08-13","scope":"insider"},{"id":9148975,"accession":"0001181431-11-031105","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-031105","line_url":"/filing/0001181431-11-031105#line-2","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP Research & Dev & CMO)","role_mark":"O","role_mark_label":"Officer (EVP Research & Dev & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Dev & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1115.0,"shares_display":"1,115","price_per_share":2.82,"price_display":"2.82","price_state":"stated","total_value":3144.3,"total_display":"3,144.30","total_whole":"3,144","shares_owned_after":4999.0,"shares_owned_after_display":"4,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-18","filed_date":"2011-05-19","scope":"insider"},{"id":9148974,"accession":"0001181431-11-031105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-031105","line_url":"/filing/0001181431-11-031105#line-1","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP Research & Dev & CMO)","role_mark":"O","role_mark_label":"Officer (EVP Research & Dev & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Dev & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1333.0,"shares_display":"1,333","price_per_share":2.73,"price_display":"2.73","price_state":"stated","total_value":3639.09,"total_display":"3,639.09","total_whole":"3,639","shares_owned_after":6114.0,"shares_owned_after_display":"6,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-17","filed_date":"2011-05-19","scope":"insider"},{"id":9101731,"accession":"0001181431-11-030231","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-030231","line_url":"/filing/0001181431-11-030231#line-3","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP Research & Dev & CMO)","role_mark":"O","role_mark_label":"Officer (EVP Research & Dev & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Dev & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1333.0,"shares_display":"1,333","price_per_share":2.84,"price_display":"2.84","price_state":"stated","total_value":3785.72,"total_display":"3,785.72","total_whole":"3,786","shares_owned_after":7447.0,"shares_owned_after_display":"7,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-16","filed_date":"2011-05-16","scope":"insider"},{"id":9101730,"accession":"0001181431-11-030231","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-030231","line_url":"/filing/0001181431-11-030231#line-2","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP Research & Dev & CMO)","role_mark":"O","role_mark_label":"Officer (EVP Research & Dev & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Dev & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":733.0,"shares_display":"733","price_per_share":2.81,"price_display":"2.81","price_state":"stated","total_value":2059.73,"total_display":"2,059.73","total_whole":"2,060","shares_owned_after":7447.0,"shares_owned_after_display":"7,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-13","filed_date":"2011-05-16","scope":"insider"},{"id":9101729,"accession":"0001181431-11-030231","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-030231","line_url":"/filing/0001181431-11-030231#line-1","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (EVP Research & Dev & CMO)","role_mark":"O","role_mark_label":"Officer (EVP Research & Dev & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Dev & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":2.91,"price_display":"2.91","price_state":"stated","total_value":1746.0,"total_display":"1,746.00","total_whole":"1,746","shares_owned_after":8180.0,"shares_owned_after_display":"8,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-12","filed_date":"2011-05-16","scope":"insider"},{"id":6070036,"accession":"0001181431-09-054339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-054339","line_url":"/filing/0001181431-09-054339#line-2","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12077.0,"shares_display":"12,077","price_per_share":8.0727,"price_display":"8.07","price_state":"stated","total_value":97493.9979,"total_display":"97,494.00","total_whole":"97,494","shares_owned_after":6665.0,"shares_owned_after_display":"6,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-30","filed_date":"2009-12-01","scope":"insider"},{"id":5801141,"accession":"0001181431-09-054079","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-09-054079","line_url":"/filing/0001181431-09-054079#line-4","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":620.0,"shares_display":"620","price_per_share":8.2743,"price_display":"8.27","price_state":"stated","total_value":5130.066,"total_display":"5,130.07","total_whole":"5,130","shares_owned_after":6665.0,"shares_owned_after_display":"6,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-27","filed_date":"2009-11-30","scope":"insider"},{"id":5801137,"accession":"0001181431-09-054079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-054079","line_url":"/filing/0001181431-09-054079#line-2","is_derivative":false,"issuer_cik":"0001385830","issuer_name":"NeurogesX Inc","issuer_ticker":"NGSX","issuer_name_source":null,"issuer_url":"/issuer/0001385830","owner_cik":"0001394522","owner_name":"Tobias Jeffrey K","owner_display_name":"Tobias Jeffrey K","owner_url":"/insider/0001394522","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9303.0,"shares_display":"9,303","price_per_share":8.3818,"price_display":"8.38","price_state":"stated","total_value":77975.8854,"total_display":"77,975.89","total_whole":"77,976","shares_owned_after":6665.0,"shares_owned_after_display":"6,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-25","filed_date":"2009-11-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":27,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001232524","name":"Jazz Pharmaceuticals plc","url":"/issuer/0001232524","role":"Officer (EVP, R&D & CMO)","n_filings":17,"first_seen":"2013-08-13","last_seen":"2015-02-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001385830","name":"NeurogesX Inc","url":"/issuer/0001385830","role":"Officer (EVP Research & Dev & CMO)","n_filings":4,"first_seen":"2009-11-30","last_seen":"2011-05-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001394522","retrieved_at":"2026-08-23T01:49:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}